↓ Skip to main content

Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study

Overview of attention for article published in Arthritis Research & Therapy, May 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study
Published in
Arthritis Research & Therapy, May 2012
DOI 10.1186/ar3838
Pubmed ID
Authors

Carlomaurizio Montecucco, Monica Todoerti, Garifallia Sakellariou, Carlo Alberto Scirè, Roberto Caporali

Abstract

In early rheumatoid arthritis (RA), low-dose oral prednisone (PDN) co-medication yields better clinical results than monotherapy with disease-modifying anti-rheumatic drugs (DMARDs). In addition, ultrasonography (US) evaluation reveals rapid and significant effects of glucocorticosteroids on subclinical synovitis. No data currently exist that examine the clinical and US results offered by glucocorticoid co-medication over DMARD monotherapy in early RA patients.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 1%
Canada 1 1%
Unknown 77 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 15%
Student > Master 11 14%
Other 8 10%
Student > Ph. D. Student 8 10%
Student > Doctoral Student 8 10%
Other 17 22%
Unknown 15 19%
Readers by discipline Count As %
Medicine and Dentistry 41 52%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Agricultural and Biological Sciences 5 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Psychology 3 4%
Other 7 9%
Unknown 15 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2012.
All research outputs
#20,657,128
of 25,374,917 outputs
Outputs from Arthritis Research & Therapy
#2,906
of 3,381 outputs
Outputs of similar age
#138,009
of 176,570 outputs
Outputs of similar age from Arthritis Research & Therapy
#62
of 75 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,570 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.